Product image of Klinotab (Minocycline) supplied by GNH India

Klinotab

Active Ingredient:
Minocycline
Origin:
EU

Klinotab (Minocycline)

Minocycline, the active ingredient in Klinotab, is a tetracycline antibiotic presented as an oral dosage form for oral use. It treats bacterial infections such as acne vulgaris, skin infections, respiratory tract infections, and urinary tract infections in adults and adolescents.

GNH India supplies Klinotab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Teofarma S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Minocycline is a tetracycline antibiotic used to treat bacterial infections of the skin, respiratory system, and urinary tract.

  • Acne vulgaris: reduces inflammatory lesions and bacterial colonisation on the skin.
  • Skin infections: resolves cellulitis, impetigo and other superficial bacterial skin conditions.
  • Respiratory tract infections: treats community‑acquired pneumonia, bronchitis and related bacterial respiratory diseases.
  • Urinary tract infections: eradicates susceptible uropathogens causing cystitis and pyelonephritis.

How It Works

  • Minocycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, blocking the attachment of aminoacyl‑tRNA. This action prevents the addition of new amino acids to the growing peptide chain, halting bacterial growth and leading to a bacteriostatic effect against susceptible Gram‑positive and Gram‑negative organisms.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Vomiting: occasional emesis after dosing.
  • Diarrhoea: loose stools, usually self‑limiting.
  • Photosensitivity: increased skin sensitivity to sunlight.
  • Dizziness: transient light‑headedness.
  • Headache: mild to moderate cranial pain.

Serious or Rare Side Effects

  • Drug‑induced lupus: systemic autoimmune reaction.
  • Stevens‑Johnson syndrome: severe skin and mucous membrane disorder.
  • Hepatic toxicity: elevated liver enzymes or hepatitis.
  • Severe hypersensitivity: anaphylaxis or angioedema.
  • Pseudotumor cerebri: increased intracranial pressure.
  • Blood dyscrasias: agranulocytosis, aplastic anaemia.

Precautions & Warnings

Before prescribing Minocycline, clinicians should consider several safety factors.

  • Assess renal function: adjust use in patients with impaired clearance.
  • Monitor liver enzymes: exercise caution in hepatic disease.
  • Avoid in known tetracycline hypersensitivity: discontinue if allergic reaction occurs.
  • Use contraception: drug may cause fetal harm; avoid pregnancy during therapy.
  • Limit sun exposure: increased risk of photosensitivity reactions.
  • Store at below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Minocycline can affect or be affected by other medicines.

Major Interactions (Avoid)

  • Anticoagulants (warfarin): increased bleeding risk.
  • Isotretinoin: heightened risk of intracranial hypertension.
  • Oral contraceptives: reduced hormonal efficacy.
  • Penicillins: antagonistic antibacterial effect.
  • Antacids containing aluminium or magnesium: decreased Minocycline absorption.

Moderate Interactions (Monitor Closely)

  • Cyclosporine: potential for increased nephrotoxicity.
  • Methotrexate: enhanced toxicity, especially hepatic.
  • Phenobarbital: may lower Minocycline serum concentrations.

Frequently Asked Questions

Klinotab contains minocycline, which is prescribed for bacterial infections such as moderate to severe acne vulgaris, various skin infections, community‑acquired respiratory tract infections, and urinary tract infections caused by susceptible organisms.

Minocycline binds to the bacterial 30S ribosomal subunit, preventing the attachment of aminoacyl‑tRNA and thereby inhibiting protein synthesis. This stops bacterial growth, producing a bacteriostatic effect against a broad range of Gram‑positive and Gram‑negative bacteria.

The specific dose of Klinotab is determined by the prescribing clinician based on the infection being treated, patient age, weight, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions exactly.

Safety data for minocycline in pregnancy and lactation are limited. The drug may cross the placenta and be excreted in breast milk, potentially causing fetal or infant harm. Clinicians should weigh the benefits against risks and consider alternative therapies when possible.

To order Klinotab, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Minocycline, the active ingredient in Klinotab, generally offers higher lipid solubility and longer half‑life than doxycycline or tetracycline, allowing once‑ or twice‑daily dosing. It also has a broader spectrum against certain resistant strains, but shares similar safety considerations such as photosensitivity.

Klinotab should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain its potency throughout its shelf life.

Klinotab is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids containing aluminium or magnesium, as these can reduce absorption.

Serious adverse events include drug‑induced lupus, Stevens‑Johnson syndrome, severe hypersensitivity reactions, pseudotumor cerebri, hepatic toxicity, and blood dyscrasias such as agranulocytosis. Patients should seek immediate medical attention if they experience rash, fever, jaundice, or neurological symptoms.

Klinotab is contraindicated in individuals with known hypersensitivity to minocycline or other tetracyclines, in pregnant women unless clearly needed, and in patients with severe renal or hepatic impairment without appropriate dose adjustment. Caution is also advised for children under eight years of age.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Minocycline

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT